DLPIC
BLUE

Davide Leone & Partners Investment Company’s bluebird bio BLUE Stock Holding History

Davide Leone & Partners Investment Company’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-3,035
Closed -$1.7M – 104
2020
Q4 		$1.7M Buy
+3,035
New +$1.92M 0.18% 53

Other funds holding BLUE

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Davide Leone & Partners Investment Company's BLUE Position: Q1 2021 in Review

Davide Leone & Partners Investment Company sold out of bluebird bio (BLUE) in Q1 2021, closing a stake of 3,035 shares — an estimated $1.7M sold.

Davide Leone & Partners Investment Company first reported a position in BLUE in Q4 2020 and held it in 1 quarter. The position peaked at $1.7M in Q4 2020. 229 funds tracked by Wall St. Rank hold BLUE as of Q1 2021.

  • Davide Leone & Partners Investment Company reported no remaining bluebird bio position as of Q1 2021 after selling out during the quarter.
  • Davide Leone & Partners Investment Company sold 3,035 bluebird bio shares in Q1 2021, an estimated $1.7M.
  • Davide Leone & Partners Investment Company first reported a position in bluebird bio in Q4 2020 and held it in 1 quarter.
  • Davide Leone & Partners Investment Company's bluebird bio position peaked at $1.7M in Q4 2020.
  • 229 funds tracked by Wall St. Rank held bluebird bio as of Q1 2021.

Based on Davide Leone & Partners Investment Company's 13F filing for Q1 2021, filed 17 May 2021.